Dilon Technologies

Dilon Technologies, founded in Newport News, US, is dedicated to advancing early cancer diagnostics through innovative molecular imaging solutions. The company's core mission is to enhance the precision and effectiveness of cancer detection, thereby improving patient outcomes. Dilon Technologies offers a range of products including the TrueView 100 Pro and Navigator 2.0 for imaging, as well as the MarginProbe for surgical applications. Their market focus is primarily on healthcare providers and institutions specializing in oncology and breast cancer treatment.

Notable affiliates and investors in Dilon Technologies include leading medical professionals and venture capital firms specializing in healthcare innovations. The company has achieved significant milestones, such as the successful deployment of their MarginProbe technology in numerous clinical settings, which has been instrumental in reducing re-operation rates for breast cancer patients. Overall, Dilon Technologies has made a substantial impact on the field of cancer diagnostics, contributing to more accurate and less invasive detection methods.